Month: April 2015

LAS VEGAS, NV–Cell MedX Corp. (OTCQB: CMXC), (the “Company”) is pleased to announce additional results of the ongoing analysis of metabolomic assays taken during the Phase 1 pilot clinical trial. The pilot clinical discovery phase trial in two diabetic subjects…